Figure 1
Figure 1. BCR triggering protects CLL cells from spontaneous apoptosis. (A) The bars display increases in mean relative viability of CLL cells cultured in medium supplemented with 10 μg/mL anti-IgM, when assessed after 24 and 48 hours, and compared with CLL cells cultured in medium without anti-IgM. Displayed are the mean (± SEM) viabilities of 15 different CLL patient samples, and the asterisks indicate significant increases in viability with P < .05. (B-C) Increased viability of CLL cells after culture with anti-IgM in the subsets of ZAP-70–positive (●, n = 9) or ZAP-70–negative CLL samples (○, n = 6). After 24 (B) and 48 hours (C) of stimulation with anti-IgM, ZAP-70–positive CLL cells displayed higher levels of cell viability than ZAP-70–negative cells; however, these differences did not reach statistical significance.

BCR triggering protects CLL cells from spontaneous apoptosis. (A) The bars display increases in mean relative viability of CLL cells cultured in medium supplemented with 10 μg/mL anti-IgM, when assessed after 24 and 48 hours, and compared with CLL cells cultured in medium without anti-IgM. Displayed are the mean (± SEM) viabilities of 15 different CLL patient samples, and the asterisks indicate significant increases in viability with P < .05. (B-C) Increased viability of CLL cells after culture with anti-IgM in the subsets of ZAP-70–positive (●, n = 9) or ZAP-70–negative CLL samples (○, n = 6). After 24 (B) and 48 hours (C) of stimulation with anti-IgM, ZAP-70–positive CLL cells displayed higher levels of cell viability than ZAP-70–negative cells; however, these differences did not reach statistical significance.

Close Modal

or Create an Account

Close Modal
Close Modal